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1996.-We investigated whether one or more factors control 
performance in 02-limited hearts. For this purpose, we mea- 
sured the dynamics of myocardial adaptation to reduced O2 
supply with a specially designed setup, analyzing early 
changes after reduction in either flow of the perfusion me- 
dium or its PO,. For 10 min, 38 isolated rat hearts underwent 
low-flow ischemia or hypoxemia, matched for OfL supply. Early 
during ischemia, developed pressure declined at a rate of 
311 5 25 mmHg/s; lactate release increased and then leveled 
off to 3.4 t 0.7 pmol/min within 2 min. During hypoxemia, 
pressure dropped initially, as observed during ischemia. 
However, it then increased before slowly decreasing. Lactate 
release during hypoxemia peaked at 13.0 2 2.3 umol/min 
after 2 min, leveling off to 3.5 t 1.3 umol/min. Glycogen 
decreased by 52 and 81% in ischemic and hypoxemic hearts, 
respectively (P < 0.05). Reexposure to ischemia or hypoxemia 
induced comparable changes in both groups. We conclude 
that, at the beginning of ischemia, a single factor does limit 
myocardial performance. This variable, which remains undis- 
turbed for 10 min, is presumably 02 availability. In contrast, 
-20 s after induction of hypoxemia, glycolytic ATP production 
can partially override low 02 availability by providing most of 
the energy needed. During repeated restriction of 02 supply, 
02 availability alone limits performance during both ischemia 
and hypoxemia. 
dynamics of adaptation; high-energy phosphates; lactate 
release 
MYOCARDIAL UNDERPERFUSION resultsin nearlyimmedi- 
ate functional decline due to the turnover rates of 
high-energy phosphates, which are fast in relation to 
their intracellular concentration (13). Under these con- 
ditions, low OS supply forces the heart to switch from 
aerobic to less efficient pathways in an attempt to 
maintain ATP homeostasis. This shift seems crucial in 
determining reperfusion injury and providing endog- 
enous myocardial protection. However, the mecha- 
nisms underlying myocardial responses to O2 depriva- 
tion are still obscure, because simultaneously occurring 
phenomena complicate a clear understanding (19). To 
gain insight into this issue, we focused on the dynam- 
ics of heart adaptation to O2 deprivation. 
The rationale underlying our approach is as follows. 
In principle, myocardial performance is comparable to 
the “product” of a multistep biochemical sequential 
process, in which factors such as PO, and energy stores 
represent the “reagents.” The slowest step, which be- 
comes the limiting factor, ultimately controls the over- 
all rate of multistep processes. If the adaptation of a 
biological system to an external stimulus is monopha- 
sic, then it is likely that a single factor limits the whole 
process. On the other hand, if the adaptation is biphasic 
or multiphasic, several factors presumably control the 
process, either simultaneously or sequentially. 
Few studies have addressed the relevance and se- 
quence of mechanisms underlying myocardial is- 
chemia. Some have described the adaptation to OZ 
deprivation in the time range of minutes (15, 16, 24, 
25>, but the models employed did not allow extrapola- 
tion to the time range of seconds. Others have exam- 
ined the second-to-second adaptation of muscle or heart 
to work jumps (1, 5, 8, 12, 20) but under conditions of 
unlimited O2 supply. 
It seems worthwhile to compare the effects due to 
low-flow ischemia at normal PO, (LFI) with those 
caused by hypoxemia at normal flow (Hyp) at the same 
degree of OZ deprivation. Indeed, such an approach has 
characterized the role of free radicals in determining 
reperfusion injury (27), lactate in downregulating myo- 
cardial function (25), and coronary flow in preserving 
the ATP pool (26). However, in these studies, data were 
taken 20 min after the onset of LFI or Hyp, when 
factors related to flow prevailed over those related to OZ 
availability (5, 14,15,30). 
We studied the dynamics of myocardial adaptation to 
LFI and Hyp in the seconds range by synchronizing the 
switch between two media perfusing isolated hearts, 
with frequent measurements of performance. The me- 
dia had the same composition but different flow or O2 
content to simulate LFI and Hyp, respectively. We show 
that a single factor presumably governs the changes 
induced by LFI, whereas during exposure to Hyp, more 
factors come into play, one of them forming part of an 
energy store. 
MATERIALS AND METHODS 
Heart perfusion. Male Sprague-Dawley rats, weighing 250- 
280 g and fed ad libitum, were anesthetized with heparinized 
thiopental sodium (100 mg/kg ip). Hearts were excised, put 
into perfusion buffer (20°C) to facilitate mounting, and imme- 
diately perfused in the Langendorff mode with Krebs- 
Henseleit buffer containing 2.0 mM free Ca2+ and 11 mM 
glucose (pH 7.4, 37°C). The medium was equilibrated at the 
desired PO, (670 or 67 mmHg) and PCO, (43 mmHg) in 
membrane oxygenators. The perfusion system was designed 
to synchronize fast data acquisition with rapid switches in 
the perfusing medium by use of a computer-operated valve. 
Thus two circuits were devised for the same medium, each 
equipped with separate pump, filter, and membrane oxygen- 
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ator. One circuit was set for baseline perfusion (flow = 15 
ml/min, PO, = 670 mmHg) and the other for either LFI 
(flow = 1.5 ml/min, PO, = 670 mmHg) or Hyp (flow = 15 
ml/min, PO, = 67 mmHg). A backpressure of 80-100 mmHg, 
applied to recirculation of the unused circuit, prevented 
undesired adjustments of flow secondary to changes in perfu- 
sion pressure and resistance. 
A latex balloon in the left ventricle was connected to a 
pressure transducer (Harvard Apparatus model 52-9966, 
Natick, MA) to measure heart rate (HR), end-diastolic pres- 
sure (EDP), left ventricular developed pressure (LVDP), and 
maximal rate of pressure development (dP/dt,,,). A trans- 
ducer connected to the aortic cannula provided the coronary 
perfusion pressure (CPP). The vascular resistance was calcu- 
lated as (CPP - EDP)/flow per gram of ventricle (6). The 
venous return was collected by a cannula in the pulmonary 
artery for measurement of PO, (Yellow Springs Instruments 
model 5300 oxygen monitor, Yellow Springs, OH; equipped 
with Teflon membranes, O.OOl-in. nominal thickness). For 
data acquisition and solenoid valve operation, LabView 3.0 
software and a NB-MIO-16 multifunction I/O board (National 
Instrument, Austin, TX) were implemented, running on an 
Apple Macintosh Quadra 700 (Cupertino, CA). The applica- 
tion controlled valve switching, monitored myocardial func- 
tion, and performed background calculations, storing data in 
work sheets. Data were sampled at 30-s intervals, but 
sampling rate was 5 s for 2 min after valve operation. 
This system monitored the second-to-second adaptation 
after the switch in perfusion medium. The short sampling 
time and negligible incidence of arrhythmias at the onset of 
LFI and Hyp allowed enough resolution to evaluate early 
myocardial responses to these interventions. At the onset of 
reperfusion or reoxygenation, severe arrhythmias made analy- 
sis of the dynamics impossible. During the change from 
baseline to LFI, the valve switching time (cl ms) limited 
response time. When Hyp started, the dead volume of the 
system was the limiting factor for the response time (-1.4 s); 
we corrected our data for this delay. The response time of the 
PO, electrode depended on dead volume (aortic cannula to 
electrode chamber including coronary vasculature, -0.5 ml), 
flow, and intrinsic response time of the device. Despite the use 
of highly permeable Teflon membranes, the overall response 
time for PO, measurements was -17 s. We therefore caution 
the reader about this artifact when dealing with the PO,-time 
curves. 
Experimental protocol. Hearts (n = 38) were stabilized for 
20 min at a flow of 15 ml/min and a PO, of 670 mmHg (02 
supply = 14.1 urn01 emin -I. heart-l). The balloon volume was 
adjusted to achieve an EDP of -10 mmHg; it was kept 
constant afterward. Hearts underwent two cycles of either 
LFI or Hyp (10 min, n = 13/group), followed by 10 min of 
reperfusion or reoxygenation. LFI and Hyp were obtained by 
reducing flow to 1.5 ml/min or PO, to 67 mmHg, respectively, 
thus matching the two conditions for 02 supply. For metabolic 
assays, additional hearts were freeze clamped at liquid 
nitrogen temperature at the end of baseline, LFI, or Hyp (n = 
4/group). 
Other measurements. Every 15 s, samples of the venous 
effluent were obtained from the pulmonary arterial catheter 
for assaying the lactate concentration (21). Net lactate re- 
lease (JLac) was calculated as lactate concentration times flow. 
Tissue HZ0 content was determined by weighing an aliquot of 
the left ventricle after 24 and 48 h at 65°C. Glycogen was 
assayed in dry tissue after amyloglucosidase digestion (4). 
The neutralized extract was also analyzed for high-energy 
phosphates and their metabolites by high-performance liquid 
chromatography methods (26). The energy charge, calculated 
as ( [ATP] + 0.5 [ADP] )/( [ATP] + [ADP] + [AMP]), is an index 
of the cardiac ability to use metabolic energy. IMP reflects the 
heart’s metabolic derangement (2). The sum of ATP, ADP, 
AMP, IMP, adenosine, inosine, hypoxanthine, xanthine, and 
urate indicates the loss of adenine nucleotides and purines 
due to the combination of high energy demand and high 
coronary flow (26). 
Statistics. Data are expressed as means 2 SE. When two 
groups were compared, the Student’s t-test for unpaired data 
was used. Comparisons of more than two groups were done by 
one-way analysis of variance (ANOVA) with either three 
groups for metabolic data (baseline, LFI, and Hyp) or four 
groups for recovery data (recovery after 1st and 2nd reduction 
in O2 supply for both LFI and Hyp). Various time courses were 
compared by ANOVA for repeated measures with four groups 
for each parameter (1st and 2nd reduction in 02 supply for 
both LFI and Hyp). I f  ANOVA was significant, selected pairs 
of data were analyzed with Fisher’s protected least signifi- 
cant difference test. The significance level was set at P = 0.05 
(2 tailed). 
RESULTS 
Control experiments and baseline data. In two hearts 
(data not shown), the myocardial “response” to switch- 
ing between two identical perfusing media was tested. 
The peak changes in CPP (~3.3 mmHg), EDP (~4.6 
mmHg), LVDP (G.9 mmHg), and HR (~6 beats/min) 
accounted for one or occasionally two sampling cycles. 
All parameters recovered fully to preswitch values 
within 5-10 s. Table 1 shows myocardial function 
during baseline. 
First exposure to LFI or Hyp. Although myocardial 
performance decreased more during LFI than during 
Hyp as expected (25), the initial rates in LVDP decline 
were similar (311 t 25 vs. 300 t 27 mmHg/s, respec- 
tively; NS). When hearts were exposed to LFI, the 
changes in LVDP and dP/dt,,,, were monophasic; they 
usually leveled off within l-2 min (Fig. 1, Left, solid 
lines). In contrast, when hearts were exposed to Hyp, 
the changes were biphasic (Fig. 1, Left, dashed lines; 
P < 0.001 vs. LFI), since a transient increase and a 
slower decrease followed an early fast decline (-20 s). 
HR was not significantly different during LFI and Hyp. 
Diastolic contracture was more pronounced in Hyp 
than in LFI hearts (P <O.OOl). 
Table 1. Myocardial performance 
during baseline perfusion 
Parameter Value 
Heart rate, beats/min 2765 10 
Developed pressure, mmHg 14425 
dPldt,,, , mmHg/s 4,643~182 
End-diastolic pressure, mmHg 10.7 + 0.6 
Perfusion pressure, mmHg 10628 
Resistance, mmHg . min. ml i 6.8 20.2 
Venous POT, mmHg 198 k 13 
Heart wet weight, mg 1,078 + 31 
Hz0 content, % 89.2k0.7 
Values are means k SE; n = 26 hearts. dP/dt,,,,, maximal rate of 
pressure development. Perfusion conditions: flow, 15 ml/min; POT 670 
mmHg; volume of intraventricular balloon adjusted to yield an 
end-diastolic pressure of - 10 mmHg. 
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Fig. 1. Adaptation of performance to low-flow ischemia or hypox- 
emia. Time courses of heart rate (HR), end-diastolic pressure, 
developed pressure, and maximal rate of pressure development 
(dP/dt,,,,,) after low-flow ischemia (solid line) or hypoxemia (dashed 
line, n = 13 hearts/group). First exposure to lo-min 02 shortage (Left) 
was followed by 10 min of reperfusion or reoxygenation (not shown) 
and by a second exposure to low-flow ischemia or hypoxemia (right). 
Two-way analysis of variance (ANOVA) for 4 groups yielded P -=c 0.001 
for all parameters except HR (P = 0.035). Vertical bars, SE. 
CPP depended on flow: at the onset of LFI, CPP fell to 
15.4 IT 1.8 mmHg (-10% of baseline value) within the 
time required for the first sampling; it decreased only 
“1 f 
slightly when Hyp started (P <O.OOl vs. LFI; Fig. 2, 15 
left). Resistance increased during LFI but decreased 10 
when Hyp began (P < 0.001). The adaptation of PO, was 5 
faster at the onset of Hyp than of LFI (P = 0.04). During 
sustained LFI, JLac increased steadily to 3.4 t 0.7 
umol/min (Fig. 2, Left). During Hyp, however, JLac 
peaked at 13.0 t 2.3 pmol/min (P = 0.01 vs. LFI) at t = 
1.25 min and then leveled off at a value similar to that 
measured during LFI (3.5 t 1.3 umol/min). 
With respect to baseline (Fig. 3), the tissue content of 
glycogen decreased by 52% after 10 min of LFI (P = 
0.05) and by 81% after Hyp (P = 0.01). Ten minutes of 
LFI did not cause significant changes in the other 
metabolic parameters, in agreement with previous 
findings (26). In contrast, 10 min of Hyp did affect these 
variables, which include ATP, phosphocreatine, energy 
charge, IMP, and the sum of adenine nucleotides and 
purines (Fig. 3). 
First recovery. Table 2 shows recovery in myocardial 
function after the first exposure to LFI or Hyp. Except 
for HR, the recovery after Hyp was slightly less than 
after LFI (NS). 
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Second exposure to LFI or Hyp. After recovery from 
the first intervention, hearts were exposed again to LFI 
or Hyp (Figs. 1 and 2, right). None of the parameters 
measured showed significant changes between the first 
and second periods of LFI. Therefore, the second expo- 
sure to LFI caused responses essentially similar to 
those observed during the first. In contrast, the second 
exposure to Hyp clearly elicited different responses: 1) 
decreases in LVDP and dP/dt,,,, were monophasic 
without marked transient rises in these variables (P 5 
0.005 vs. 1st exposure to Hyp, NS vs. 2nd exposure to 
LFI); 2) rate of LVDP changes was slower (154 t 15 
mmHg/s; P = 0.05 vs. 1st exposure to Hyp); and 3) JLac 
peak was lower (7.7 - . + 2 5 umol/min; P < 0.05 vs. 1st 
exposure to Hyp) and similar to that during LFI 
exposure. Other characteristics were similar during 
first and second exposures to Hyp. These include CPP, 
resistance, and EDP, which remained different from the 
pattern observed during LFI (P < 0.001). Overall, with 
the second reduction in O2 supply, Hyp hearts tended to 
behave similarly to LFI hearts. Nevertheless, other 
variables related to flow were still different. 
Second recovery. Table 2 shows myocardial perfor- 
mance after the second reduction in O2 supply. Al- 
though the second exposure to LFI did not cause 
appreciable changes, such an exposure to Hyp induced 
a further depression (P = 0.05) of myocardial perfor- 
mance for LVDP and dP/dt,,,. 
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Fig. 2. Adaptation of performance to low-flow ischemia or hypox- 
emia. Time course of coronary perfusion pressure, resistance, venous 
PO,, and net lactate release. Same conditions as in Fig. 1. Two-way 
ANOVAfor 4 grouns vielded P < 0.001 for all narameters. 
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ATP Inosine-S-monophosphate 
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Fig. 3. Tissue metabolites at end of baseline (open bars) 
and of first exposure to low-flow ischemia (hatched bars) 
T 
or hypoxemia-(solid bars). Data are expressed in umol/g 
dry tissue except for glycogen (mg/g dry wt) and energy 
charge (nondimensional). One-way ANOVA for 3 groups 
yielded P 5 0.04. Means + SE are given; 72 = -4 
hearts/group. +’ Significant difference from baseline. 
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DISCUSSION 
Acute responses to LFI and Hyp. The myocardial 
adaptations to LFI and Hyp were different. Although 
the changes in LVDP and dP/dt,,, at the onset of LFI 
were fast and monophasic, those observed during Hyp 
were similar to the LFI changes during the initial 20 s 
only. Transient increases in pressure during Hyp fol- 
lowed, however. When reperfused or reoxygenated 
hearts were exposed again to LFI or Hyp, the responses 
to LFI and Hyp were superimposable and similar to 
those observed during the first exposure to LFI (obvi- 
ously except flow-related parameters, i.e., CPP, EDP, 
and resistance). Comparable rates of change during the 
initial 20 s of Hyp and LFI strongly suggest that the 
main factor acutely limiting myocardial performance 
Table 2. A4yocardial performance at end 
of recovery from first and second exposure 
to low-flow ischemia or hypoxemia 
After Low-Flow 
Ischemia After Hypoxemia 
Parameter 1st 2nd 1st 2nd 
Heart rate, 9 of base- 
line 98”l 95rl 9623 9123 
Developed pressure, c/c 
of baseline 83+5 7425 68 + 5:s 51+5+ 
dP&,,ax 7 ‘2% of baseline 7524 6425 
59 5 4::: 4325-k 
Increase of end-diastolic 
pressure over base- 
line value, mmHg 25 5 7 28 + 7 3127 4929 
Increase of perfusion 
pressure over base- 
line value, mmHg 41-12 43212 27212 40213 
Values are means + SE; IZ = 13 hearts. For perfusion conditions, 
see Table 1. One-way analysis of variance yielded P < 0.001 for 
developed pressure and dPldt,,,,, , and NS for the other parameters. 
No significant differences were detected between 1st and 2nd expo- 
sures to low-flow ischemia and hypoxemia. Significance vs. low-flow 
ischemia in the corresponding situation: ':'P = 0.05; -i-P = 0.001. 
could be Oz availability, in agreement with studies in 
dog gastrocnemius muscle (15). Later, flow-related 
events become predominant, taking over control of 
myocardial performance. The critical time, when these 
overriding events prevail over those related to Oz 
availability, depends on experimental model, flow, and 
energy supply-to-demand ratio. 
The Oz supply during baseline (14.1 umolmin-l. 
heart-l or 13.1 umol.minlgl) was slightly higher 
than that of hearts in vivo (8.5-10.1 pmol*minlgl), 
assuming a flow of 0.70-0.85 ml*minlgl, a hemoglo- 
bin concentration of 155 g/l, and a 98% Oz saturation at 
100 mmHg PO,. Therefore we suppose that O2 supply 
during LFI or Hyp was reduced to -l/lo of the in vivo 
value. This condition was associated with downregula- 
tion of myocardial activity during LFI due to low 
coronary flow, known to depress lactate washout, inhib- 
iting glycolysis by cell acidification (25). The poor 
ability of Hyp hearts to rephosphorylate ADP to ATP, 
due to excessive energy demand with respect to supply, 
leads to extensive formation ofATP catabolites, some of 
which permeate the cell membrane. They are therefore 
lost under high-flow conditions (26). The higher tissue 
content of IMP also reflects the greater metabolic 
derangement in Hyp hearts (2). Relatively low flow in 
LFI hearts leads to downregulation of cardiac function 
and a better maintenance of high-energy phosphates 
(26), which i n t urn improves recovery. The duration of 
exposure to LFI or Hyp is sufficient to allow hearts to 
develop different extents of reperfusion injury, as in 
studies in which the shortage of O2 supply lasted 20 
min (27). 
Time-resolved analysis of regulatory pathways. The 
time resolution of the patterns observed with exposure 
to LFI and Hyp allows the identification of pathways 
asynchronous with other phenomena observed. If the 
adaptation of a biological system to an external stimu- 
lus is monophasic, then a single factor probably limits 
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the whole process. For example, intracellular Ca2+ 
transients may theoretically play a significant role, 
since contractile dysfunction is related to changes in 
Ca2+ handling and myofilament Ca2+ sensitivity during 
Hyp and global no-flow ischemia, respectively (16). 
However, alterations in Ca2+ transients usually occur 
on a time scale much longer than that observed in this 
study. Presumably, they are a consequence, not the 
cause, of the altered metabolic status in skeletal and 
heart muscles (18). In Hyp hearts, the steady increase 
in EDP, which appears to reflect the long-term changes 
in the Ca2- transient secondary to glycogen and ATP 
depletion (17), supports this hypothesis. It is unlikely 
that EDP changes are linked to stress-strain relations 
(3), since the time course of this variable does not 
correspond to that of resistance. 
In principle, the biphasic adaptation at the onset of 
Hyp may be due to disturbances secondary to reduced 
transmural tissue pressure. This attenuation could 
depress force development by affecting alignment of 
and tension on the myofibril. However, the adaptation 
of CPP and resistance to LFI is fast (~5 s) compared 
with adaptation to Hyp. In the latter case, early 
changes do not occur, ruling out primary involvement of 
coronary perfusion inhomogeneities due to hypoxic 
vasodilation. Short-term coronary reactivity may be 
due to the garden-hose effect (32), since the associate 
“erectile” effect increases myocardial wall tone and, 
therefore, EDP. However, CPP and resistance follow 
reproducible patterns from the first to the second 
exposure to Hyp. In contrast, the patterns of myocar- 
dial contractility are strikingly different. Therefore 
explaining the different dynamics of performance adjust- 
ment with different coronary reactivities is difficult. 
The JLac peak, observed during the first exposure to 
Hyp, coincided with the transient increases in myocar- 
dial activity. Furthermore, JLac peaks did not occur 
during LFI; they were much lower with the second 
exposure to Hyp, corresponding to reduced increases in 
function under these conditions. It is thus tempting to 
associate transient increases in myocardial function 
with bursts of lactate release, indicating reduced ATP 
production due to O2 limitation (12). We found no 
evidence for a transient nonaerobic energy source 
sustaining ATP production at the onset of LFI. This fits 
the criteria of time correspondence among the various 
patterns observed and of quantitative consistency. In- 
deed, glycolytic bursts can already occur within 5 s 
after a work jump. In addition, glycogenolysis can be 
maximally active within 30 s (5) due to rapid activation 
of fructokinase and phosphorylase b (l), and glycolytic 
ATP production may account for up to one-half of the 
total energy required by Hyp hearts (25). 
Energy stores. What is the role of the various energy 
stores to supply energy at the onset of O2 shortage? The 
amount of O2 stored in dissolved form or bound to 
myoglobin is irrelevant, since interruption of O2 supply 
affects O2 uptake within 4 s (10). Full assessment of the 
acute changes in aerobic metabolism, i.e., within sec- 
onds, is difficult because of the low response time of the 
PO, electrode (see above). However, the fast response of 
venous PO, at the onset of Hyp compared with the slow 
response of performance suggests that changes in 
aerobic metabolism are not crucial in our model. In fact, 
as shown earlier, aerobic metabolism does not vary in 
LFI and Hyp hearts at any energy demand level (25). 
The intracellular stores of phosphocreatine are suffi- 
cient to support myocardial activity for <3--S s. These 
values are based on the reported ATP turnover rate 
during LFI and Hyp (25) and the changes observed in 
tissue ATP and phosphocreatine levels (26). The ab- 
sence of fatty acids in the medium prevents mobiliza- 
tion of triacylglycerol or fatty acid stores, because these 
stores remain unchanged in isolated hearts subjected 
to 90 min of ischemia (31). 
Despite the high glucose concentration in the me- 
dium, which should have saturated the glucose trans- 
port system (34), our hearts used substantial amounts 
of glycogen during Hyp. When we again exposed reoxy- 
genated hearts to Hyp, they therefore depended to a 
larger extent on exogenous glucose. Fast glycogen 
utilization is consistent with accelerated glycogenolysis 
when fatty acids are absent from the medium (22). Our 
data are also consistent with computer simulations. 
These predict that the rapid increase in energy demand 
is first met by glycogen breakdown, followed by in- 
creased glucose uptake from the perfusion fluid (1). 
Implications and limitations of this study. Increased 
tissue glycogen improves the metabolic status by main- 
taining ATP during anaerobiosis (7) and by retarding 
loss of ATP and its catabolites (29). It provides an 
explanation for the worse recovery after Hyp than after 
LFI. Tissue glycogen may be crucial in the early phases 
of O2 shortage, since it fuels glycolysis, further blunting 
myocardial downregulation. 
A limitation of this study is that myocardial perfor- 
mance in the two study groups was not the same before 
the second reduction in O2 supply, since recoveries from 
the first intervention are different. We minimized this 
problem by halving the duration of LFI and Hyp with 
respect to that used in our previous studies (26, 27) to 
reduce functional depression in Hyp hearts. We cannot 
exclude that the remaining differences, even if small, 
before the second intervention have affected the results 
obtained. 
In the present study, we did not use erythrocytes in 
the perfusion medium for several reasons. First, we 
wanted to exclude nonspecific phenomena related to 
capillary blood clotting and leukocyte infiltration. Sec- 
ond, with erythrocytes, perfusion is heterogeneous, 
because of expected differences in capillary hematocrit, 
erythrocyte transit times (23), spacing within the capil- 
lary (9), and velocities (28) during normal perfusion, 
LFI, and Hyp. Heterogenous perfusion results in differ- 
ent O2 unloading rates and unpredictable local O2 
supply, which would have been detrimental in this 
study. Third, the relatively slow erythrocyte O2 off- 
loading kinetics (11) would complicate understanding 
of the second-to-second dynamics of cardiac adaptation 
to LFI and Hyp. Fourth, unpredictable shifts of the 
02-hemoglobin dissociation curve along the capillary 
due to changing local conditions of DH, Pco~, and 
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lactate (33) make it difficult to reduce O2 supply by 
exactly 90%, a necessary condition to compare LFI and 
HYP* 
Finally, we want to caution against the transfer of the 
rationale underlying simple biochemical in vitro pro- 
cesses to complex in vivo systems. 
In conclusion, we provide evidence that, at the begin- 
ning of ischemia, a single factor, presumably the O2 
availability, does limit myocardial performance, which 
remains undisturbed up to 10 min. In contrast, -20 s 
after the start of hypoxemia, glycolytic ATP production 
could partially override low O2 availability by providing 
the bulk of the energy needed. During the second 
restriction of OS supply, the Oz availability appears the 
only factor limiting performance in both ischemic and 
hypoxemic hearts. 
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